Panelists discuss how they use staging systems, such as the Mackie classification (mild, moderate, severe), and incorporate corneal sensitivity testing into comprehensive eye exams for better risk stratification.

Panelists discuss how early recognition of stage 1 neurotrophic keratitis (NK) leads to better treatment outcomes and how to identify key risk factors, including diabetes, herpes infections, and long-term glaucoma medication use.

Researchers will investigate a gene in the eye that is crucial for normal vision, but can cause retinal diseases when mutated that often lead to blindness.

wavelight plus was first launched in China, with several European and Asia-Pacific markets following suit.

Award winners will be recognized during the Academy 2025 meeting in Boston, Massachusetts, running from October 8 to 11.

Xiidra is a prescription eye drop used to treat the signs and symptoms of dry eye disease (DED) and works by targeting the source of inflammation.

The trial will evaluate the solution in treating significant, chronic night driving impairment in keratorefractive patients with reduced mesopic vision.

The lens portfolio includes spherical, aspheric, toric, multifocal, multifocal toric, reverse geometry, and keratoconic contact lenses.

Catch up on the top stories in optometry during the week of September 1-September 5.

Dan Ignaszewski, executive director of the Alliance for Eye and Vision Research and the National Alliance for Eye and Vision Research, provides insight into the new campaign and how to get involved.

Findings from the retrospective, observational study support the potential anti-inflammatory benefits of the drug class.

Panelists discuss how to perform corneal sensitivity testing using methods ranging from cotton swabs to the more quantitative Brill esthesiometer, emphasizing that testing should become routine practice.

Panelists discuss how to differentiate neurotrophic keratitis (NK) from dry eye disease and blepharitis by focusing on patient history, chief complaints, and the critical importance of corneal sensitivity testing.

Calista Ming, OD, FAAO, FSLS, provides 3 cases of how to fit specialty lenses at the right time for patients.

Outlook Therapeutics seeks FDA clarity on ONS-5010 after a complete response letter, aiming to address efficacy concerns for wet AMD treatment.